Ikemoto, Satoshi
National Institute on Drug Abuse (NIDA),
United States
2025 Rank: 80111
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Psychiatry
Rank in SubField 1: 3454 out of 360881 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 80111 | 89907 |
| Total Cites | 249 | 253 |
| H-index | 7 | 7 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 77 | 77 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 136 | 136 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 236 | 240 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 220 | 221 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
1.58%
|
|
Ikemoto, Satoshi
National Institute on Drug Abuse (NIDA),
United States
2024 Rank: 70107
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Psychiatry
Rank in SubField 1: 3197 out of 341636 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70107 | 72613 |
| Total Cites | 257 | 270 |
| H-index | 7 | 8 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 72 | 74 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 151 | 156 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 243 | 254 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 221 | 226 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.19 |
| Self-Citation Percentage |
4.81%
|
|
Ikemoto, Satoshi
National Institute on Drug Abuse (NIDA),
United States
2023 Rank: 43924
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Psychiatry
Rank in SubField 1: 2286 out of 323273 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43924 | 46205 |
| Total Cites | 302 | 337 |
| H-index | 8 | 8 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 100 | 107 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 196 | 215 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 282 | 316 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 261 | 268 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.26 |
| Self-Citation Percentage |
10.39%
|
|
Ikemoto, Satoshi
National Institute on Drug Abuse (NIDA),
United States
2022 Rank: 31766
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Psychiatry
Rank in SubField 1: 1841 out of 305851 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31766 | 35000 |
| Total Cites | 342 | 368 |
| H-index | 10 | 10 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 106 | 109 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 218 | 227 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 335 | 360 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 293 | 300 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.23 |
| Self-Citation Percentage |
7.07%
|
|
Ikemoto, Satoshi
National Institutes of Health (NIH),
United States
2021 Rank: 28892
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Psychiatry
Rank in SubField 1: 1638 out of 278898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28892 | 32235 |
| Total Cites | 539 | 572 |
| H-index | 12 | 12 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 170 | 174 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 346 | 358 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 520 | 552 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 450 | 460 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.24 |
| Self-Citation Percentage |
5.77%
|
|
Ikemoto, Satoshi
National Institute on Drug Abuse,
United States
2020 Rank: 23582
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Psychiatry
Rank in SubField 1: 1384 out of 227881 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23582 | 27365 |
| Total Cites | 480 | 491 |
| H-index | 12 | 12 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 139 | 139 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 281 | 281 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 457 | 467 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 382 | 388 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.27 |
| Self-Citation Percentage |
2.24%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.